Khaled El‐Adl

3.3k citations
90 papers · 2.8k · h-index 36

Impact in

  • Toxicology top 0.5%
    • Bioactive Compounds and Antitumor Agents
  • Organic Chemistry top 0.5%
    • Synthesis and biological activity
    • Synthesis and Biological Evaluation
    • Quinazolinone synthesis and applications
    • Click Chemistry and Applications
    • Synthesis and Characterization of Heterocyclic Compounds

Papers in

  • Organic Chemistry 66
    • Synthesis and biological activity 39
    • Synthesis and Biological Evaluation 26
    • Quinazolinone synthesis and applications 22
    • Click Chemistry and Applications 10
  • Molecular Biology 54
    • Cancer therapeutics and mechanisms 18
    • Angiogenesis and VEGF in Cancer 13
    • Phenothiazines and Benzothiazines Synthesis and Activities 9
Co-authors
Helmy Sakr (23 shared papers)Abdel‐Ghany A. El‐Helby (17 shared papers)Ibrahim H. Eissa (23 shared papers)Hamada S. Abulkhair (18 shared papers)Rezk R. Ayyad (11 shared papers)Ahmed A. Al‐Karmalawy (5 shared papers)Sanadelaslam S. A. El‐Hddad (12 shared papers)Nour E. A. Abd El‐Sattar (9 shared papers)
Journals
Archiv der Pharmazie (26 papers)Bioorganic Chemistry (12 papers)RSC Advances (10 papers)New Journal of Chemistry (4 papers)Medicinal Chemistry Research (4 papers)
Partner nations
EgyptSaudi ArabiaIraq

In The Last Decade

Khaled El‐Adl

88 papers receiving 2.8k citations

Peers

Khaled El‐Adl
Comparison fields: 5 of 85
  • Toxicology 310
  • Organic Chemistry 2.0k
  • Molecular Biology 1.3k
  • Oncology 479
  • Computational Theory and Mathematics 224
Replace Ahmed B. M. Mehany with:
Ahmed B. M. Mehany Egypt
Bahaa G. M. Youssif Egypt
Mostafa M. Ghorab Egypt
Mohamed Abdel‐Aziz Egypt
Hamada S. Abulkhair Egypt
Hazem Elkady Egypt
Sahar M. Abou‐Seri Egypt
Tarfah Al‐Warhi Saudi Arabia
Stéphane Léonce France
Yeh‐Long Chen Taiwan
Khaled El‐Adl relative to Ahmed B. M. Mehany Egypt Ahmed B. M. Mehany's profile →
Citations per field
00.5×2×3.1×
Ahmed B. M. Mehany · 1×
Citations per year

Countries citing papers authored by Khaled El‐Adl

Since Specialization
Citations

This map shows the geographic impact of Khaled El‐Adl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled El‐Adl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled El‐Adl more than expected).

Fields of papers citing papers by Khaled El‐Adl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled El‐Adl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled El‐Adl. The network helps show where Khaled El‐Adl may publish in the future.

Co-authors

The 25 scholars most cited alongside Khaled El‐Adl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Khaled El‐Adl Line = papers co-authored together Khaled El‐Adl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors
Archiv der Pharmazie ·Abdel‐Ghany A. El‐Helby, Helmy Sakr, Ibrahim H. Eissa, Hamada S. Abulkhair, Ahmed A. Al‐Karmalawy, Khaled El‐Adl
2019140
2
Benzoxazole/benzothiazole‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations
Archiv der Pharmazie ·Abdel‐Ghany A. El‐Helby, Helmy Sakr, Ibrahim H. Eissa, Ahmed A. Al‐Karmalawy, Khaled El‐Adl
2019103
3
Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation
Bioorganic Chemistry ·Khaled El‐Adl, Helmy Sakr, Reda G. Yousef, Ahmed B. M. Mehany, Ahmed M. Metwaly, Mostafa A. Elhendawy, Mohamed M. Radwan, Mahmoud A. ElSohly, Hamada S. Abulkhair, Ibrahim H. Eissa
202193
4
Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme
Bioorganic Chemistry ·Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr, Ibrahim H. Eissa, Sanadelaslam S. A. El‐Hddad, Fatma M.I.A. Shoman
202091
5
Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents
Bioorganic Chemistry ·Mohamed Ayman El‐Zahabi, Helmy Sakr, Khaled El‐Adl, Mohamed F. Zayed, Adel S. Abdelraheem, Sally I. Eissa, Hazem Elkady, Ibrahim H. Eissa
202091
6
Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors
Bioorganic & Medicinal Chemistry ·Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad, Hazem A. Mahdy, Mohamed M. Khalifa, H. El-Nagar, Ahmed B. M. Mehany, Ahmed M. Metwaly, Mostafa A. Elhendawy, Mohamed M. Radwan, Mahmoud A. ElSohly, Ibrahim H. Eissa
202085
7
Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors
Bioorganic Chemistry ·Nashwa M. Saleh, M. S. A. El‐Gaby, Khaled El‐Adl, Nour E. A. Abd El‐Sattar
202081
8
Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation
Bioorganic Chemistry ·Ibrahim H. Eissa, Abdel‐Ghany A. El‐Helby, Hazem A. Mahdy, Mohamed M. Khalifa, H. El-Nagar, Ahmed B. M. Mehany, Ahmed M. Metwaly, Mostafa A. Elhendawy, Aly F. Mohamed, Mahmoud A. ElSohly, Khaled El‐Adl
202080
9
New quinoxaline-2(1H)-ones as potential VEGFR-2 inhibitors: design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations
New Journal of Chemistry ·Reda G. Yousef, Helmy Sakr, Ibrahim H. Eissa, Ahmed B. M. Mehany, Ahmed M. Metwaly, Mostafa A. Elhendawy, Mohamed M. Radwan, Mahmoud A. ElSohly, Hamada S. Abulkhair, Khaled El‐Adl
202176
10
Design, Synthesis, Molecular Docking, and Anticancer Activity of Phthalazine Derivatives as VEGFR‐2 Inhibitors
Archiv der Pharmazie ·Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad, Helmy Sakr, Khaled El‐Adl, Mamdouh M. Ali, Fathalla Khedr
201775
11
Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors
Bioorganic Chemistry ·Asmaa M Sayed, Fatma A. Taher, Mohammad Abdel-Samad, M. S. A. El‐Gaby, Khaled El‐Adl, Nashwa M. Saleh
202171
12
Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents
Bioorganic Chemistry ·Nour E. A. Abd El‐Sattar, Khaled El‐Adl, Maher A. El‐Hashash, Samir A. Salama, Mostafa M. Elhady
202167
13
Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors
Bioorganic Chemistry ·Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr, Alaa Elwan
202064
14
Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors
Archiv der Pharmazie ·Ibrahim H. Eissa, Ahmed M. Metwaly, Amany Belal, Ahmed B. M. Mehany, Rezk R. Ayyad, Khaled El‐Adl, Hazem A. Mahdy, Mohammed S. Taghour, Kamal M. El‐Gamal, Mohamad E. El‐Sawah, Souad A. El‐Metwally, Mostafa A. Elhendawy, Mohamed M. Radwan, Mahmoud A. ElSohly
201964
15
Pharmacophore‐linked pyrazolo[3,4‐d]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies
Archiv der Pharmazie ·Ahmed A. Abdel Gaber, Ahmed El-morsy, Farag F. Sherbiny, Ashraf H. Bayoumi, Kamal M. El‐Gamal, Khaled El‐Adl, Ahmed A. Al‐Karmalawy, Rogy R. Ezz Eldin, Marwa A. Saleh, Hamada S. Abulkhair
202162
16
The antimicrobial potential and pharmacokinetic profiles of novel quinoline-based scaffolds: synthesis and in silico mechanistic studies as dual DNA gyrase and DHFR inhibitors
New Journal of Chemistry ·Mohamed H. El‐Shershaby, Kamal M. El‐Gamal, Ashraf H. Bayoumi, Khaled El‐Adl, Mohamed Alswah, Hany E. A. Ahmed, Ahmed A. Al‐Karmalawy, Hamada S. Abulkhair
202159
17
[1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4′,3′-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies
Bioorganic & Medicinal Chemistry ·Khaled El‐Adl, Mohamed‐Kamal Ibrahim, Mohamed S. Alesawy, Ibrahim H. Eissa
202057
18
Phthalazine‐based VEGFR‐2 inhibitors: Rationale, design, synthesis, in silico, ADMET profile, docking, and anticancer evaluations
Archiv der Pharmazie ·Fathalla Khedr, Mohamed‐Kamal Ibrahim, Ibrahim H. Eissa, Hamada S. Abulkhair, Khaled El‐Adl
202156
19
Design, synthesis, in silico ADMET profile and GABA‐A docking of novel phthalazines as potent anticonvulsants
Archiv der Pharmazie ·Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad, Mohamed F. Zayed, Hamada S. Abulkhair, Hazem Elkady, Khaled El‐Adl
201953
20
Design, synthesis, molecular modeling and biological evaluation of novel 2,3-dihydrophthalazine-1,4-dione derivatives as potential anticonvulsant agents
Journal of Molecular Structure ·Abdel Ghany El-Helby, Rezk R. Ayyad, Helmy Sakr, Adel S. Abdelrahim, Khaled El‐Adl, Farag S. Sherbiny, Ibrahim H. Eissa, Mohamed M. Khalifa
201653

About Khaled El‐Adl

Khaled El‐Adl is a scholar working on Organic Chemistry, Molecular Biology, Oncology, Toxicology and Pathology and Forensic Medicine, having authored 90 papers that have together received 2.8k indexed citations. Recurring topics across this work include Synthesis and biological activity (39 papers), Synthesis and Biological Evaluation (26 papers), Quinazolinone synthesis and applications (22 papers), Cancer therapeutics and mechanisms (18 papers), Angiogenesis and VEGF in Cancer (13 papers), HER2/EGFR in Cancer Research (12 papers), Click Chemistry and Applications (10 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (9 papers). The work is most often cited by research in Toxicology (310 citations), Organic Chemistry (2.0k citations), Molecular Biology (1.3k citations), Oncology (479 citations) and Computational Theory and Mathematics (224 citations). Khaled El‐Adl has collaborated with scholars based in Egypt, Saudi Arabia and Iraq. Frequent co-authors include Helmy Sakr, Abdel‐Ghany A. El‐Helby, Ibrahim H. Eissa, Hamada S. Abulkhair, Rezk R. Ayyad, Ahmed A. Al‐Karmalawy, Sanadelaslam S. A. El‐Hddad, Nour E. A. Abd El‐Sattar, Nashwa M. Saleh and Ahmed B. M. Mehany. Their work appears in journals such as Archiv der Pharmazie, Bioorganic Chemistry, RSC Advances, New Journal of Chemistry and Medicinal Chemistry Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed B. M. MehanyBreakdown of academic impact, for papers by Bahaa G. M. YoussifBreakdown of academic impact, for papers by Mostafa M. GhorabBreakdown of academic impact, for papers by Mohamed Abdel‐AzizBreakdown of academic impact, for papers by Hamada S. AbulkhairBreakdown of academic impact, for papers by Hazem ElkadyBreakdown of academic impact, for papers by Sahar M. Abou‐SeriBreakdown of academic impact, for papers by Tarfah Al‐WarhiBreakdown of academic impact, for papers by Stéphane LéonceBreakdown of academic impact, for papers by Yeh‐Long Chen